Collaborative Fund Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$620K Buy
2,658
+660
+33% +$153K 0.33% 83
2026
Q2
$423K Buy
+1,998
New +$392K 0.25% 122

Other funds holding DGX

Collaborative Fund Advisors's DGX Position: Q3 2026 in Review

Collaborative Fund Advisors increased its Quest Diagnostics (DGX) stake by 33% in Q3 2026, buying an estimated $153K and bringing the position to 2,658 shares worth $620K. The position accounts for 0.33% of the portfolio, ranked #83.

Collaborative Fund Advisors first reported a position in DGX in Q2 2026 and has held it in 2 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Collaborative Fund Advisors held 2,658 shares of Quest Diagnostics worth $620K as of Q3 2026.
  • Collaborative Fund Advisors bought 660 Quest Diagnostics shares in Q3 2026, an estimated $153K.
  • Quest Diagnostics made up 0.33% of Collaborative Fund Advisors's portfolio in Q3 2026, its #83 holding.
  • Collaborative Fund Advisors first reported a position in Quest Diagnostics in Q2 2026 and has held it in 2 quarters since.
  • 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.